Research progress and therapeutic prospect of PHF5A acting as a new target for malignant tumors

Zhejiang Da Xue Xue Bao Yi Xue Ban. 2022 Nov 25;51(5):647-655. doi: 10.3724/zdxbyxb-2022-0459.

Abstract

PHD-finger domain protein 5A (PHF5A) is a member of the PHD-finger like protein superfamily and widely expressed in the nucleus of eukaryotes. The PHD-finger like domain is a protein-DNA or protein-protein interaction region. In addition to regulate alternative splicing of target genes as a spliceosome protein subunit, PHF5A is also involved in pluripotency maintenance of embryonic stem cells, chromatin remodeling, DNA damage repair, embryogenesis and histomorphological development. Recently, increasing studies have focused on exploring spliceosome-related and non-spliceosome-related functions of PHF5A and its relationship with the tumorigenesis, development and patient prognosis of various malignant tumors, such as breast cancer, lung cancer and colorectal cancer. The underlying mechanisms of PHF5A may include mediating aberrant alternative splicing of target genes, activating downstream signaling pathways as an oncogene/protein, and regulating abnormal gene transcription as a nuclear transcription factor or cofactor. Besides, PHF5A was also found to be involved in the growth regulation of cancer stem cells. In this review, we aimed to delineate the structural and functional characteristics of PHF5A, to summarize its role in the occurrence and development of malignant tumors hitherto described, and to provide potential targets for anti-tumor therapy.

Keywords: Alternative splicing; Cancer stem cell; Embryonic stem cell; Malignant tumor; PHD-finger domain protein 5A; Review.

Publication types

  • Review

MeSH terms

  • Alternative Splicing
  • Carrier Proteins / genetics
  • Carrier Proteins / metabolism
  • Humans
  • Lung Neoplasms*
  • RNA-Binding Proteins* / genetics
  • RNA-Binding Proteins* / metabolism
  • Trans-Activators / genetics
  • Trans-Activators / metabolism

Substances

  • RNA-Binding Proteins
  • Carrier Proteins
  • Trans-Activators
  • PHF5A protein, human

Grants and funding

国家自然科学基金(82072585); 安徽省自然科学基金(2008085MH238); 安徽省高校优秀青年人才支持计划(gxyq2022042); 蚌埠医学院研究生科研创新计划(Byycx20046)